Startup Dossier
Apmonia Therapeutics
Apmonia Therapeutics is a clinical-stage biotech developing targeted cancer therapies by addressing the extracellular matrix (ECM), modeling protein–protein interactions to generate therapeutic candidates aimed at improving drug penetration and efficacy in solid tumors.
active
Typestartup
SectorBioTech
LocationReims
About
Apmonia Therapeutics is a clinical-stage biotech developing targeted cancer therapies by addressing the extracellular matrix (ECM), modeling protein–protein interactions to generate therapeutic candidates aimed at improving drug penetration and efficacy in solid tumors.
Structural DNA
Legal Name
APMONIA THERAPEUTICS
SIREN
849959390
Founders & Team
Funding Lineage
Series A
Capital Grand Est (Lead)
€10.0M
Jan 2026
Undisclosed
EIC Accelerator (Lead)
€7.0M
Jul 2024
Seed
Bpifrance (Lead)
€2.5M
Sept 2022
Programs
i-Nov
2023Santé
i-Lab
2020